3-O-beta-glucopyranosyl-(1→6)-beta-glucopyranosyl-1-octen-3-ol - Compound Card

3-O-beta-glucopyranosyl-(1→6)-beta-glucopyranosyl-1-octen-3-ol

Select a section from the left sidebar

3-O-beta-glucopyranosyl-(1→6)-beta-glucopyranosyl-1-octen-3-ol

Structure
Zoomed Structure
  • Family: Plantae - Acanthaceae
  • Kingdom: Plantae
  • Class: Glycoside
    • Subclass: Matsutake Alcohol Glycoside
Canonical Smiles CCCCCC(O[C@H]1OC(CO[C@H]2OC(CO)[C@H](C([C@@H]2O)O)O)[C@H](C([C@@H]1O)O)O)C=C
InChI InChI=1S/C20H36O11/c1-3-5-6-7-10(4-2)29-20-18(27)16(25)14(23)12(31-20)9-28-19-17(26)15(24)13(22)11(8-21)30-19/h4,10-27H,2-3,5-9H2,1H3/t10?,11?,12?,13-,14-,15?,16?,17+,18+,19+,20+/m1/s1
InChIKey SSIWNCYQUXTPDX-PJHJIEHSSA-N
Formula C20H36O11
HBA 11
HBD 7
MW 452.5
Rotatable Bonds 11
TPSA 178.53
LogP -2.24
Number Rings 2
Number Aromatic Rings 0
Heavy Atom Count 31
Formal Charge 0
Fraction CSP3 0.9
Exact Mass 452.23
Number of Lipinski Rule Violations 2
# Species Family Kingdom NCBI Taxonomy ID
1 Sanchezia nobilis Acanthaceae Plantae 71612

Showing of synonyms

  • Abd Ellah AE, Mohamed KM, et al. (2013). Matsutake alcohol glycosides from Sanchezia nobilis. Chemistry of Natural Compounds,2013,48(6),930-933. [View]
Pubchem: 162870561
Nmrshiftdb2: 70092835

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1COC2CCCCO2

Level: 1

Mol. Weight: 452.5 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 452.5 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.7
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
-5.14
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-0.98

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.75
Plasma Protein Binding
57.92
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
3.17
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-3.29
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.41
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
5.51
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-31.04
Rat (Acute)
2.21
Rat (Chronic Oral)
3.4
Fathead Minnow
1.97
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
476.7
Hydration Free Energy
-8.32
Log(D) at pH=7.4
0.36
Log(P)
-0.52
Log S
-1.35
Log(Vapor Pressure)
-17.32
Melting Point
119.95
pKa Acid
5.43
pKa Basic
5.62
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 3 0.8734
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 3 0.8734
Lysozyme C II P11941 LYSC2_ONCMY Oncorhynchus mykiss 3 0.7532
Lysozyme C II P11941 LYSC2_ONCMY Oncorhynchus mykiss 3 0.7532

Download SDF